Provided by Tiger Fintech (Singapore) Pte. Ltd.

Emergent BioSolutions

6.24
-0.0100-0.16%
Post-market: 6.23-0.0098-0.16%19:57 EDT
Volume:693.92K
Turnover:4.38M
Market Cap:338.69M
PE:-2.54
High:6.42
Open:6.31
Low:6.23
Close:6.25
Loading ...

Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08

GlobeNewswire
·
21 Mar

Hikma: Aims to Make Kloxxado Available via Prescription as Early as 2026

THOMSON REUTERS
·
20 Mar

Hikma Announces Health Canada Approval of Kloxxado® (Naloxone Hcl) Nasal Spray 8 Mg

THOMSON REUTERS
·
20 Mar

Emergent BioSolutions Completes Sale of Baltimore-Bayview Facility to Syngene International

MT Newswires Live
·
20 Mar

BRIEF-Emergent Biosolutions finalizes sale of Baltimore-Bayview manufacturing site to Syngene International

Reuters
·
20 Mar

Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International

THOMSON REUTERS
·
20 Mar

Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International

GlobeNewswire
·
20 Mar

Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales to Supply International Customers With Five Critical Medical Countermeasure Products

THOMSON REUTERS
·
18 Mar

Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales to Supply International Customers with Five Critical Medical Countermeasure Products

GlobeNewswire
·
18 Mar

Emergent BioSolutions Reinforces its Commitment to Expanding Access to NARCAN® Nasal Spray by Supporting Organizations with New Opioid Overdose Preparedness Programs

GlobeNewswire
·
13 Mar

INDIA STOCKS-Indian stocks set to open lower, tracking global market sell-off

Reuters
·
11 Mar

Emergent BioSolutions Sells Baltimore Facility to Syngene

TIPRANKS
·
11 Mar

BUZZ-Emergent BioSolutions drops after Syngene buys co's unit for $36.5 mln

Reuters
·
11 Mar

CORRECTED-India's Syngene International acquires first US biologics facility for $36.5 mln

Reuters
·
10 Mar

Emergent to Sell Baltimore-Bayview Facility for $36.5 Million

MT Newswires Live
·
10 Mar

Emergent BioSolutions Inc - to Sell Baltimore-Bayview Facility for $36.5 Million

THOMSON REUTERS
·
10 Mar

Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International

THOMSON REUTERS
·
10 Mar

Press Release: Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International

Dow Jones
·
10 Mar

Jazz Offers to Buy Chimerix for $935M to Boost Oncology Portfolio

Zacks
·
06 Mar

Emergent BioSolutions Inc. (NYSE:EBS) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Simply Wall St.
·
06 Mar